These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 2810823)

  • 1. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.
    Filella X; Molina R; Mengual PJ; Jo J; Ballesta AM
    J Nucl Biol Med (1991); 1991; 35(3):158-61. PubMed ID: 1816871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
    Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.
    Nakayama T; Watanabe M; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
    Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
    Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
    Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
    Takahashi Y; Mai M
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G; Müller-Ruchholtz W
    Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma.
    Iemura K; Moriya Y
    Eur J Surg Oncol; 1993 Oct; 19(5):439-42. PubMed ID: 8405479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
    Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.